Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
IMPACT - The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
Int J Psychiatry Clin Pract. 2022 Mar;26(1):85-91. doi: 10.1080/13651501.2021.1904997. Epub 2021 Apr 7.
The Bipolar Depression Rating Scale (BDRS) is a structured rating scale designed to assess depressive and mixed symptoms in bipolar disorder (BD). Previous studies evaluating the scale have been performed on small samples or on patients in a depressive phase, but not on patients in a mixed or manic phase. This study evaluated the Persian version of the BDRS regarding its factor structure, reliability, and validity in a large sample of Iranian women with BD in a depressive or mixed/manic phase.
Three-hundred and one female BD inpatients completed the BDRS, the Beck Depression Inventory-II (BDI-II), the Hamilton Depression Rating Scale (HDRS), the Montgomery-Åsberg Depression Rating Scale (MADRS), and the Young Mania Rating Scale (YMRS).
The BDRS demonstrated a three-factor structure with good reliability. The BDRS and its psychological and somatic symptom clusters had stronger correlations with other measures of depressive symptoms than a measure of mania. The BDRS mixed symptom cluster also had a stronger correlation with a measure of mania than other measures of depression, supporting the scales' convergent and discriminant validity.
The BDRS demonstrated psychometric validity in assessing depressive and mixed symptoms in Iranian women with BD in a depressive or mixed/manic phase.KEY POINTSThe Bipolar Depression Rating Scale (BDRS) was validated in Iranian women with BD.The BDRS showed a three-factor structure, similar to the original validation.The BDRS had good reliability based on Omega and test-retest coefficients.The findings provided evidence for the convergent and discriminant validity of the BDRS.
双相抑郁评定量表（BDRS）是一种结构化的评定量表，旨在评估双相情感障碍（BD）中的抑郁和混合症状。以前评估该量表的研究是在小样本或处于抑郁期的患者中进行的，但不是在处于混合或躁狂期的患者中进行的。本研究评估了 BDRS 的波斯语版本，在处于抑郁或混合/躁狂期的大量伊朗女性 BD 住院患者中，评估其因子结构、信度和效度。
301 名女性 BD 住院患者完成了 BDRS、贝克抑郁量表第二版（BDI-II）、汉密尔顿抑郁评定量表（HDRS）、蒙哥马利-阿斯伯格抑郁评定量表（MADRS）和 Young 躁狂评定量表（YMRS）。
BDRS 表现出良好信度的三因子结构。BDRS 及其心理和躯体症状群与其他抑郁症状测量指标的相关性强于躁狂症状测量指标。BDRS 混合症状群与躁狂症状测量指标的相关性也强于其他抑郁症状测量指标，支持了量表的收敛和区分效度。
BDRS 在评估伊朗女性 BD 患者处于抑郁或混合/躁狂期时，表现出了心理测量学效度。
BDRS 在伊朗 BD 女性中得到验证。
BDRS 呈现出与原始验证相似的三因子结构。
BDRS 的 Omega 和重测信度系数表明其具有良好的信度。
研究结果为 BDRS 的收敛和区分效度提供了证据。
